67 related articles for article (PubMed ID: 1730260)
1. Genetic correction of cultured T cells from an adenosine deaminase-deficient patient: characteristics of non-transduced and transduced T cells.
Braakman E; Van Beusechem VW; Van Krimpen BA; Fischer A; Bolhuis RL; Valerio D
Eur J Immunol; 1992 Jan; 22(1):63-9. PubMed ID: 1730260
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow gene therapy for adenosine deaminase deficiency.
Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
[TBL] [Abstract][Full Text] [Related]
3. In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: role of CD8+ cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient.
Kawamura N; Ariga T; Ohtsu M; Kobayashi I; Yamada M; Tame A; Furuta H; Okano M; Egashira M; Niikawa N; Kobayashi K; Sakiyama Y
J Immunol; 1999 Aug; 163(4):2256-61. PubMed ID: 10438969
[TBL] [Abstract][Full Text] [Related]
4. Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo.
Kaptein LC; Breuer M; Valerio D; van Beusechem VW
Gene Ther; 1998 Mar; 5(3):320-30. PubMed ID: 9614551
[TBL] [Abstract][Full Text] [Related]
5. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
Hershfield MS
Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
[TBL] [Abstract][Full Text] [Related]
6. [Study of T cell-directed gene transfer for a patient with ADA deficiency].
Sakiyama Y; Ariga T; Kawamura N
Nihon Rinsho; 1998 Mar; 56(3):696-700. PubMed ID: 9549359
[TBL] [Abstract][Full Text] [Related]
7. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the induced T cells in a ADA-defective case 4 years after gene induction targeted at the peripheral T cells and a simulation study on gene re-induction].
Ichimura R
Hokkaido Igaku Zasshi; 2004 Nov; 79(6):647-57. PubMed ID: 15675295
[No Abstract] [Full Text] [Related]
9. Bone marrow gene transfer in three patients with adenosine deaminase deficiency.
Hoogerbrugge PM; van Beusechem VW; Fischer A; Debree M; le Deist F; Perignon JL; Morgan G; Gaspar B; Fairbanks LD; Skeoch CH; Moseley A; Harvey M; Levinsky RJ; Valerio D
Gene Ther; 1996 Feb; 3(2):179-83. PubMed ID: 8867866
[TBL] [Abstract][Full Text] [Related]
10. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer.
Kantoff PW; Kohn DB; Mitsuya H; Armentano D; Sieberg M; Zwiebel JA; Eglitis MA; McLachlin JR; Wiginton DA; Hutton JJ
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6563-7. PubMed ID: 3489233
[TBL] [Abstract][Full Text] [Related]
11. [The gene therapy for a patient with ADA deficiency; report of the first gene therapy trial in Japan].
Ariga T; Kawamura N; Sakiyama Y
Nihon Rinsho; 1997 Jun; 55(6):1572-9. PubMed ID: 9200950
[TBL] [Abstract][Full Text] [Related]
12. Expression of human adenosine deaminase in murine haematopoietic progenitor cells following retroviral transfer.
Belmont JW; Henkel-Tigges J; Chang SM; Wager-Smith K; Kellems RE; Dick JE; Magli MC; Phillips RA; Bernstein A; Caskey CT
Nature; 1986 Jul 24-30; 322(6077):385-7. PubMed ID: 3016551
[TBL] [Abstract][Full Text] [Related]
13. Retroviral-mediated gene transfer into mammalian cells.
Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
[TBL] [Abstract][Full Text] [Related]
14. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
Martín M; Huguet J; Centelles JJ; Franco R
J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y; Ariga T; Ohtsu M
Nihon Rinsho; 2005 Mar; 63(3):448-52. PubMed ID: 15773344
[TBL] [Abstract][Full Text] [Related]
16. Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.
Gaspar HB; Bjorkegren E; Parsley K; Gilmour KC; King D; Sinclair J; Zhang F; Giannakopoulos A; Adams S; Fairbanks LD; Gaspar J; Henderson L; Xu-Bayford JH; Davies EG; Veys PA; Kinnon C; Thrasher AJ
Mol Ther; 2006 Oct; 14(4):505-13. PubMed ID: 16905365
[TBL] [Abstract][Full Text] [Related]
17. Long-term in vivo expression of the MFG-ADA retroviral vector in rhesus monkeys transplanted with transduced bone marrow cells.
Kaptein LC; Van Beusechem VW; Rivière I; Mulligan RC; Valerio D
Hum Gene Ther; 1997 Sep; 8(13):1605-10. PubMed ID: 9322093
[TBL] [Abstract][Full Text] [Related]
18. Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.
Culver KW; Osborne WR; Miller AD; Fleisher TA; Berger M; Anderson WF; Blaese RM
Transplant Proc; 1991 Feb; 23(1 Pt 1):170-1. PubMed ID: 1846711
[No Abstract] [Full Text] [Related]
19. Transfer of the adenosine deaminase (ADA) gene of a B-lymphoblastoid cell line (LCL) to an ADA-deficient LCL by a microcell-mediated chromosome transfer technique.
Sawami H; Ito K; Norioka M; Monden S; Fujita M; Uchino H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1033-44. PubMed ID: 2588953
[TBL] [Abstract][Full Text] [Related]
20. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]